← All FR Documents
Notice

National Cancer Institute; Notice of Closed Meetings

📖 Research Context From Federal Register API

Key Dates
Citation: 90 FR 4752
February 12, 2025.
Public Participation

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

February 12, 2025.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-00977
FR Citation90 FR 4752
TypeNotice
PublishedJan 16, 2025
Effective Date-
RIN-
Docket ID-
Pages4752–4753 (2 pages)
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (666 words · ~4 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>National Cancer Institute; Notice of Closed Meetings</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> National Cancer Institute Special Emphasis Panel; PLCO U01 SEP Review Meeting. <E T="03">Date:</E> February 12, 2025. <E T="03">Time:</E> 10:00 a.m. to 4:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Shakeel Ahmad, Ph.D., Branch Chief, Research Technology and Contract Review, Branch Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850, 240-276-6442, <E T="03">ahmads@mail.nih.gov.</E> <E T="03">Name of Committee:</E> National Cancer Institute Special Emphasis Panel; TEP-7: SBIR Contract Review Meeting (Review of SBIR Topics 431 and 439). <E T="03">Date:</E> February 20, 2025. <E T="03">Time:</E> 12:00 p.m. to 4:00 p.m. <E T="03">Agenda:</E> To review and evaluate contract proposals. <E T="03">Address:</E> National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W254, Rockville, Maryland 20850. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Susan Lynn Spence, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Rockville, Maryland 20850, 240-620-0819, <E T="03">susan.spence@nih.gov</E> . <E T="03">Name of Committee:</E> National Cancer Institute Special Emphasis Panel; SEP-9: NCI Clinical and Translational Cancer Research. <E T="03">Date:</E> February 27, 2025. <E T="03">Time:</E> 10:00 a.m. to 4:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W542, Rockville, Maryland 20850. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Biman Chandra Paria, Ph.D., Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W542, Rockville, Maryland 20850, 240-858-3814, <E T="03">pariab@mail.nih.gov</E> . <E T="03">Name of Committee:</E> National Cancer Institute Special Emphasis Panel; NCI Research Specialist Award (R50) Clinician Scientist. <E T="03">Date:</E> March 11-12, 2025. <E T="03">Time:</E> 10:00 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W526, Rockville, Maryland 20850. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Viktoriya Sidorenko, Ph.D., Scientific Review Officer, Program and Review Extramural Staff Training Office, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W526, Rockville, Maryland 20850, 240-276-5073, <E T="03">viktoriya.sidorenko@nih.gov</E> . <E T="03">Name of Committee:</E> National Cancer Institute Special Emphasis Panel; NCI SEP: The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals (R01 and R21). <E T="03">Date:</E> March 20, 2025. <E T="03">Time:</E> 9:00 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W244, Rockville, Maryland 20850. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Ryan Gleason, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W244, Rockville, Maryland 20850, 240-276-7329, <E T="03">ryan.gleason@nih.gov</E> . <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED>Dated: January 10, 2025.</DATED> <NAME>David W. Freeman,</NAME> Supervisory Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-00977 Filed 1-15-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison.